Life Science Executive Awards
Monday 16 November 2026City Central at the HAC, London, UKVenture Capital Firm of the Year
This award recognises a European venture capital firm that has outperformed peers, created value and demonstrated truly outstanding investment decision making.
Congratulations to this year's finalist roster.
There will be 1st (Gold), 2nd (Silver), and 3rd (Bronze) place announcements in each category, with 1st place exclusively awarded the bespoke trophy.
Criteria & Judging
It is open to European life science companies only.
Qualifying criteria:
- Open to venture capital Firms only
- Firm must have more than 20% portfolio holdings in healthcare and/or life sciences companies
- Firms must have headquarters in Europe
- Period to be judged review is between 1 September 2025 and 1 August 2026
Judges will be paying particular attention to:
- Evidence of innovative company creation and deal-making strategies
- Volume and value of investments made in the qualifying timeline
- Number of lead investments made
- Number / quality of successful exits
- Number / value of new funds raised
- Fund performance and returns to LPs
